Singapor - Ingliż - HSA (Health Sciences Authority)

gsk consumer healthcare singapore pte. ltd. - diclofenac potassium - tablet, film coated - 12.5 mg - diclofenac potassium 12.5 mg

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - diclofenac potassium, quantity: 12.5 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; stearic acid; lactose monohydrate; colloidal anhydrous silica; titanium dioxide; povidone; microcrystalline cellulose; magnesium stearate; maize starch; hypromellose - temporary relief of painful conditions such as headache, dental pain, period pain, rheumatic and muscular pain, backache. temporary relief of symptoms of colds and flu (including aches and pains, sore throat pain). reduces fever.

Armenja - Ingliż - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis consumer health s.a. - diclofenac (diclofenac diethylamine) - gel for external use - 20mg/g

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - diclofenac potassium, quantity: 25 mg - tablet, sugar coated - excipient ingredients: macrogol 8000; iron oxide red; sucrose; colloidal anhydrous silica; magnesium stearate; sodium starch glycollate; purified talc; maize starch; povidone; calcium phosphate; microcrystalline cellulose; titanium dioxide - as short-term treatment (up to one week) for the relief of acute pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea. indications as at 16 november 1998: as short-term treatment (up to one week) for the relief of acute pain states in which there is an inflammatory component. treatment of acute migraine attacks (with or without aura). symptomatic treatment of primary dysmenorrhoea.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 1 mg/ml;  ;   - eye drops, solution - 1 mg/ml - active: diclofenac sodium 1 mg/ml     excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid hydroxypropyl gamma-cyclodextrin propylene glycol trometamol tyloxapol water for injection

Iżrael - Ingliż - Ministry of Health

novartis israel ltd - diclofenac sodium - eye drops - diclofenac sodium 1 mg/ml - diclofenac - diclofenac - post-operative inflammation following cataract extraction. control of ocular pain and discomfort associated with corneal epithelial defects after laser excimer prk or accidental trauma.

Malta - Ingliż - Medicines Authority

novartis consumer health uk limited - diclofenac sodium 10 mg/g - gel

Malta - Ingliż - Medicines Authority

novartis consumer health uk limited - diclofenac sodium - gel - diclofenac sodium 20 mg/g - topical products for joint and muscular pain

Malta - Ingliż - Medicines Authority

laboratoires thea 12 rue louis blériot, 63017 clermont-ferrand cedex 2, france - diclofenac sodium - eye drops, solution - diclofenac sodium 1 mg/ml - ophthalmologicals

Malta - Ingliż - Medicines Authority

haleon hellas single member societe anonyme, under the distinctive title of haleon hellas, 274, kifissias ave, 15232 chalandri, athens, greece - diclofenac sodium - gel - diclofenac sodium 10 mg/g - topical products for joint and muscular pain